http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#Head
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#assertion
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#provenance
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#pubinfo
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#assertion
http://purl.obolibrary.org/obo/DOID_1558
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1558
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB14209
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association
http://www.w3.org/2000/01/rdf-schema#label
"Trandolapril tablets are contraindicated in patients who are hypersensitive to this product, in patients with hereditary/idiopathic angioedema and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Do not co-administer aliskiren with trandolapril in patients with diabetes (see PRECAUTIONS, Drug Interactions Trandolapril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer trandolapril tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS"
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB14209
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#provenance
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#pubinfo
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig
http://purl.org/nanopub/x/hasSignature
KqbwjYH2U/Rh2leW3QeQZWMiuN1bWjM+pbnr7JCU0Xwu+HHpf1UnVfGMyh/clYtMPx+AMMTUDOVwnGmGmvv676OO0LgjDvLj03Wq6rl4zpVdWeoFCp7MWMI2HMnF0f8AGXSPGKv6pHt/P2imxErJ0nLuLx+RYp8fYQcpI4Phhl8=
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
http://purl.org/dc/terms/created
2021-08-25T13:54:45.572+02:00
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAZpvxRwIvdSLBNjyJ1KeDeHAL7ushHyTv_i-6LNY_TZg
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY